Article
SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection.
PLoS pathogens - 1 Jan 2022
Khateeb Dina, Gabrieli Tslil, Sofer Bar, Hattar Adi, Cordela Sapir, Chaouat Abigael, Spivak Ilia, Lejbkowicz Izabella, Almog Ronit, Mandelboim Michal, Bar-On Yotam
Abstract excerpt
In-depth analysis of SARS-CoV-2 quasispecies is pivotal for a thorough understating of its evolution during infection. The recent deployment of COVID-19 vaccines, which elicit protective anti-spike neutralizing antibodies, has stressed the importance of uncovering and characterizing SARS-CoV-2 variants with mutated spike proteins. Sequencing databases have allowed to follow the spread of SARS-CoV-2 variants that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.